Search Results - "Keyel ME"

The changes of immune function after neuroblastoma chemotherapy and the prediction of potential immune targets.

Authors: Ma, Yunfei Su, Yan Huang, Jing et al.

Source: BMC Medical Genomics. 8/20/2025, Vol. 18 Issue 1, p1-13. 13p.

Efficacy of anti-GD2 antibody immunotherapy with filgrastim and teceleukin versus standard treatment with sargramostim, aldesleukin and isotretinoin in children with high-risk neuroblastoma.

Authors: Nitani C Hara J Kawamoto H et al.

Source: International journal of clinical oncology [Int J Clin Oncol] 2026 Jul 23. Date of Electronic Publication: 2026 Jul 23.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

Advancements in neuroblastoma treatment: FDA-approved drugs and role of phytochemicals.

Authors: Rajpoot S Kumar R Singh R et al.

Source: Molecular biology reports [Mol Biol Rep] 2025 May 29; Vol. 52 (1), pp. 516. Date of Electronic Publication: 2025 May 29.

Publication Type: Journal Article; Review

Journal Info: Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE

Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy.

Authors: Keyel ME Reynolds CP

Source: Biologics : targets & therapy [Biologics] 2018 Dec 21; Vol. 13, pp. 1-12. Date of Electronic Publication: 2018 Dec 21 (Print Publication: 2019).

Publication Type: Journal Article; Review

Journal Info: Publisher: Dove Medical Press (NZ) Country of Publication: New Zealand NLM ID: 101321511 Publication Model: eCollection Cited Medium: Print ISSN: 1177-5475 (Print) Linking ISSN: 11775475 NLM ISO Abbreviation: Biologics Subsets: PubMed not MEDLINE

Exploration of the molecular mechanism of intercellular communication in paediatric neuroblastoma by single-cell sequencing.

Authors: Chu, Jing¹ (AUTHOR) chujing198603@163.com

Source: Scientific Reports. 11/21/2023, Vol. 13 Issue 1, p1-19. 19p.

Safety and efficacy of dinutuximab in the treatment of neuroblastoma: A review.

Authors: Mohd, Ahmed Bassam Mohd, Omar B. Alabdallat, Yasmeen J. et al.

Source: Journal of Research in Medical Sciences. Sep2023, Vol. 28, p1-7. 7p.

Enhanced Anticancer Effect of Temozolomide through Synergistic Combination with Diltiazem in Neuroblastoma (SH-SY5Y) Cell Line.

Alternate Title: Temozolomidin Diltiazem ile Sinerjik Kombinasyonunun Nöroblastom (SH-SY5Y) Hücre Hattında Artmış Antikanser Etkisi.

Authors: KARADEMİR, Mustafa SURARDAMAR, Saime

Source: Cumhuriyet Medical Journal. haz2023, Vol. 45 Issue 2, p46-51. 6p.

Cytokine Immunotherapy for Neuroblastoma.

Authors: Dowsey, Martin L.¹ mldowsey@yahoo.com

Source: Science INSIGHTS. 1/31/2023, Vol. 42 Issue 1, p787-792. 6p.

miR-132-3p regulates antibody-mediated complement-dependent cytotoxicity in colon cancer cells by directly targeting CD55.

Authors: Fan, Yu Liao, Juan Wang, Yu et al.

Source: Clinical & Experimental Immunology. Jan2023, Vol. 211 Issue 1, p57-67. 11p. 1 Diagram, 1 Chart, 4 Graphs.

Silencing E3 Ubiqutin ligase ITCH as a potential therapy to enhance chemotherapy efficacy in p53 mutant neuroblastoma cells.

Authors: Meng, Jinhong Tagalakis, Aristides D. Hart, Stephen L.

Source: Scientific Reports. 1/23/2020, Vol. 10 Issue 1, p1-12. 12p.

The gamma delta T/NK cell product GADEKILL as a novel immunotherapeutic tool for neuroblastoma patients: role of B7H6 and BTN2A1 in tumor cell killing.

Authors: Morandi F Della Lastra M Pastorino F et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jan 30; Vol. 17, pp. 1755500. Date of Electronic Publication: 2026 Jan 30 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Dinutuximab beta in the treatment of high-risk neuroblastoma: A follow-up of a case series in Bratislava.

Authors: Achbergerová M Hederová S Hrašková A et al.

Source: Medicine [Medicine (Baltimore)] 2022 Jan 28; Vol. 101 (4), pp. e28716.

Publication Type: Journal Article

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE

Characterization of glycosphingolipids from gastrointestinal stromal tumours.

Authors: Santos, Licínia Jin, Chunsheng Gazárková, Taťána et al.

Source: Scientific Reports. 11/9/2020, Vol. 10 Issue 1, pN.PAG-N.PAG. 1p.

Prospects of anti-GD2 immunotherapy for retinoblastoma.

Authors: Zhang X You W Wang Y et al.

Source: Frontiers in immunology [Front Immunol] 2024 Nov 15; Vol. 15, pp. 1499700. Date of Electronic Publication: 2024 Nov 15 (Print Publication: 2024).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [⁶⁴Cu]Cu-NOTA-ch14.18/CHO.

Authors: Trautwein NF Schwenck J Seitz C et al.

Source: Theranostics [Theranostics] 2024 Jan 20; Vol. 14 (3), pp. 1212-1223. Date of Electronic Publication: 2024 Jan 20 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE

Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor.

Authors: Espinosa-Cotton M Cheung NV

Source: Frontiers in oncology [Front Oncol] 2021 Nov 19; Vol. 11, pp. 772862. Date of Electronic Publication: 2021 Nov 19 (Print Publication: 2021).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Reduction of CD11b⁺ myeloid suppressive cells augments anti-neuroblastoma immune response induced by the anti-GD2 antibody ch14.18/CHO.

Authors: Siebert N Zumpe M von Lojewski L et al.

Source: Oncoimmunology [Oncoimmunology] 2020 Oct 24; Vol. 9 (1), pp. 1836768. Date of Electronic Publication: 2020 Oct 24.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Electronic Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology

Yoga as a non-pharmacologic therapy to reduce dinutuximab-induced pain in patients with neuroblastoma.

Authors: Parisio KN Kulp T Heil M et al.

Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Apr; Vol. 71 (4), pp. e30845. Date of Electronic Publication: 2024 Jan 08.

Publication Type: Journal Article

Journal Info: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma.

Authors: Arlt B Zasada C Baum K et al.

Source: International journal of cancer [Int J Cancer] 2021 Mar 01; Vol. 148 (5), pp. 1219-1232. Date of Electronic Publication: 2020 Dec 17.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

IGF2BP1 fosters an immunosuppressive tumor microenvironment in high-risk neuroblastoma, contributing to their resistance to immunotherapy.

Authors: Dhamdhere MR Gowda CP Imamura Y et al.

Source: Oncoimmunology [Oncoimmunology] 2025 Dec 31; Vol. 14 (1), pp. 2584408. Date of Electronic Publication: 2025 Dec 02.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE